THE EXPERIENCE OF TUBERCULOSIS PATIENTS WHO DISCONTINUE TREATMENT: A PHENOMENOLOGICAL STUDY IN BANDUNG REGENCY

Hendra Gunawan, Iyep Dede Supriyatna

Abstract


Loss to follow-up threatens tuberculosis (TB) control in Bandung Regency, where 18 patients in six districts discontinued treatment in 2023. Previous studies have mostly identified factors associated with loss to follow-up; this study instead describes the experience as a continuous process, from the initial treatment phase and the decision to stop, through its consequences, to the motivation to resume treatment. The aim was to analyze the experiences of TB patients in Bandung Regency regarding treatment discontinuation. A qualitative study with a phenomenological approach was conducted. Five participants (two men and three women) were selected purposively and interviewed in depth using a semi-structured guide. Data were analyzed using Colaizzi’s method, and trustworthiness was ensured through credibility, dependability, confirmability, and transferability. Four themes emerged: the duration of the initial treatment, reasons for treatment discontinuation, the consequences of discontinuing treatment, and the motivation to resume treatment. The themes are interconnected, running from patient-related and economic factors and their physical and psychological impacts to the role of family and health worker support. Addressing treatment discontinuation in Bandung Regency requires a comprehensive approach that goes beyond providing free medication to include strengthening family support, educating patients on completing treatment, and empowering health volunteers to monitor patients in their service areas. These findings matter because they show local TB programs where, along the patient’s treatment journey, targeted support can keep patients in care.

Keywords


Bandung Regency; Lived Experiences; Lost to Follow-Up; Patients; Tuberculosis

Full Text:

PDF

References


World Health Organization. Global tuberculosis report 2025. Geneva: World Health Organization; 2025.

Fithri, E., Herdianti, H., Sabri, S., Herman, H., & Oktarizal H. A DETERMINANT MODEL OF TUBERCULOSIS TREATMENT COMPLIANCE MANAGEMENT BASED ON BEHAVIOR, FAMILY SUPPORT, AND HEALTH WORKERS: BATAM CASE STUDY. Jambura J Heal Sci Res. 2026;8(3):185–201.

Lv H, Wang L, Zhang X, Dang C, Liu F, Zhang X, et al. Further analysis of tuberculosis in eight high ‑ burden countries based on the Global Burden of Disease Study 2021 data. Infect Dis Poverty 2024;1370 doi101186/s40249-024-01247-8.

Sinha R, Fitriangga A, Sharan AP, Zaman SU, Putra IWGAE, Alex A et al. Prevalence of lost to follow-up in drug-sensitive TB patients in WHO SEAR countries: a systematic review and meta-analysis. Indian J Tuberc 2026;73(2)261-9 doi101016/j.ijtb202601008.

Azam M, Hanan L, Azinar M, Khasanah AF, Fibriana AI, Yunus M, et al. Barriers to treatment completion among drug- sensitive tuberculosis patients : evidence from Indonesia ’ s tuberculosis surveillance system. Osong Public Heal Res Perspect 2026;17(2)145-54 doi1024171/j.phrp20250325.

Ritonga IL, Setyowati S, Nursasi AY. Exploring the tuberculosis medication program in Indonesia as perceived by patients and their families : A qualitative study. Belitung Nurs J 2023;9(2)124-31 doi1033546/bnj2484.

Syamsir SB, Permatasari H, Setiawan A et al. Experiences of Patients with Tuberculosis Who Underwent Completed TB Treatment during the COVID-19 Pandemic in Indonesia : A Qualitative Study. Int J Community Based Nurs Midwifery 2023;11(4)226-36 doi1030476/IJCBNM2023987682257.

Kementerian Kesehatan RI. Profil Kesehatan Indonesia Tahun 2024. 2025.

Profil Kesehatan Jawa Barat Tahun 2024. Bandung; 2025.

Penabulu Kabupaten Bandung. Data Kader TB Penabulu Kab. Bandung. Kabupaten Bandung; 2024.

Tok PSK, Wong LP, Liew SM, Razali A, Mahmood MI, Chinnayah T et al. A qualitative exploration of tuberculosis patients who were lost to follow-up in Malaysia. PLoS One 2023;18(9)e0289222 doi101371/journal.pone0289222.

Walker EF, Flook M, Rodger AJ, Fielding KL SH. Quantifying non- ­ adherence to anti- ­ tuberculosis treatment due to early discontinuation : a systematic literature review of timings to loss to follow- ­ up. BMJ Open Respir Res 2024;11e001894 doi101136/bmjresp-2023-001894.

Agus Z, Junadi P RR. Factors Associated for Anti Tuberculosis Treatment Non-Adherence Among Tuberculosis Patients: Scoping Review. Media Publ Promosi Kesehat Indones 2024;7(9)2273-9 doi1056338/mppki.v7i95874.

Khaitan A, Rai SK, Krishnan A, Gupta SK, Kant S KG. “ Better to Die Than Take These Medicines ”: A Community-Based Qualitative Study on the Determinants of Treatment Loss-to-Follow-Up in Tuberculosis Patients in District Faridabad ,. Cureus 2022;14(5):e25030 doi:107759/cureus25030.

Soedarsono S, Mertaniasih NM, Kusmiati T, Permatasari A, Juliasih NN, Hadi C et al. Determinant factors for loss to follow ‑ up in drug ‑ resistant tuberculosis patients : the importance of psycho ‑ social and economic aspects. BMC Pulm Med 2021;21360 doi101186/s12890-021-01735-9.

Mishra P, Sharma RK, Yadav R, Rao VG, Nigam S, Lingala MA et al. Reasons for loss to follow-up ( LTFU ) of pulmonary TB ( PTB ) patients : A qualitative study among Saharia , a particularly vulnerable tribal group of Madhya Pradesh , India. PLoS One 2021 Dec 23;16(12)e0261152 doi 101371/journal.pone0261152.

Agbeko CK, Mallah MA, He B, Liu Q, Song H WJ. Mental Health Status and Its Impact on TB Treatment and Its Outcomes : A Scoping Literature Review. Front Public Heal 2022 May 31;10855515 doi 103389/fpubh2022855515.

Zuhair RD IZ. Original Article Risk Factors for Treatment Drop Out Among Pulmonary Tuberculosis Patients at the UPT Public Health Center in Medan Sunggal. IJHS 2024 Apr 15;12(1)36-42 doi 1015850/ijihs.v12.n13544.

Setiyadi A, Noviana U, Sholikhah EN, Akhmadi MH. Community Empowerment through Cadres in the Tuberculosis Program : A Scoping Review. Iran J Public Heal 2025 Jul;54(7)1339-1349 doi 1018502/ijph.v54i719113.

Maharja R, Wahiduddin, Moedjiono AI, Zulkifli A, Noor NN, Ishak H et al. Determinants of loss to follow-up among MDR-TB patients. Indian J Forensic Med Toxicol 2021 Apr-Jun;15(2)3297-3302 doi 1037506/ijfmt.v15i214894.




DOI: https://doi.org/10.35971/jjhsr.v8i4.41262

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Creative Commons Licence
 

 

Jambura Journal of Health Sciences and Research is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License

</p